Literature DB >> 11985531

Cerebrospinal fluid affects phenotype and functions of myeloid dendritic cells.

M Pashenkov1, M Söderström, Y-M Huang, H Link.   

Abstract

Myeloid (CD11c+) dendritic cells (DC) are present in cerebrospinal fluid (CSF), as well as in the meninges and choroid plexus. Functional studies of these DC are hindered or impossible. To obviate this problem, we investigated the effects of CSF supernatants from patients with non-inflammatory neurological diseases (NIND), multiple sclerosis (MS), bacterial meningitis (BM) and Lyme meningoencephalitis (LM) on immature monocyte-derived DC (moDC) from healthy donors. CSF supernatants caused maturation of moDC (MS > LM > NIND > BM), as reflected by a decrease in CD1a, and an increase in HLA-DR, CD80 and CD86 expression. The maturation effect of MS CSF and LM CSF could be blocked by anti-TNF-alpha MoAb or recombinant human IL-10. moDC cultured with BM CSF either remained immature or turned into CD14+ macrophage-like cells and were relatively inefficient at inducing T cell responses in vitro. In contrast, moDC cultured with LM CSF induced strong Th1 responses. Both BM CSF and LM CSF contained IFN-gamma, a cytokine that augments IL-12 production by moDC and hence should confer an ability to induce a Th1 response. However, BM CSF also contained high levels of IL-10, which could antagonize the effects of IFN-gamma on moDC. moDC cultured with MS CSF induced a higher production of IFN-gamma from T cells compared to moDC cultured with NIND CSF or BM CSF. In summary, soluble factors present in the CSF may influence the phenotype and functions of meningeal, choroid plexus and CSF DC which, in turn, may have an impact on the character of intrathecal T cell responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11985531      PMCID: PMC1906399          DOI: 10.1046/j.1365-2249.2002.01850.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

1.  Human peripheral blood contains two distinct lineages of dendritic cells.

Authors:  S P Robinson; S Patterson; N English; D Davies; S C Knight; C D Reid
Journal:  Eur J Immunol       Date:  1999-09       Impact factor: 5.532

2.  Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations.

Authors:  P G McMenamin
Journal:  J Comp Neurol       Date:  1999-03-22       Impact factor: 3.215

3.  Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells.

Authors:  M J Carson; C R Reilly; J G Sutcliffe; D Lo
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

4.  Recruitment, activation and proliferation of CD8+ memory T cells in an immunoprivileged site.

Authors:  P G Stevenson; C R Bangham; S Hawke
Journal:  Eur J Immunol       Date:  1997-12       Impact factor: 5.532

5.  TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.

Authors:  F Geissmann; P Revy; A Regnault; Y Lepelletier; M Dy; N Brousse; S Amigorena; O Hermine; A Durandy
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

6.  Vasoactive intestinal peptide synergizes with TNF-alpha in inducing human dendritic cell maturation.

Authors:  Y Delneste; N Herbault; B Galea; G Magistrelli; I Bazin; J Y Bonnefoy; P Jeannin
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

7.  HLA-DR-positive dendritic cells of the normal human choroid plexus: a potential reservoir of HIV in the central nervous system.

Authors:  A Hanly; C K Petito
Journal:  Hum Pathol       Date:  1998-01       Impact factor: 3.466

Review 8.  Myelin basic protein in cerebrospinal fluid and other body fluids.

Authors:  J N Whitaker
Journal:  Mult Scler       Date:  1998-02       Impact factor: 6.312

9.  Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings.

Authors:  M Söderström; J Ya-Ping; J Hillert; H Link
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

10.  Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid.

Authors:  A Leonardi; S Penco; C Gramigni; C Bason; G Ribizzi; P Gazzola; G L Mancardi; G Bianchi-Scarrà; M Abbruzzese; C Garrè
Journal:  Acta Neurol Scand       Date:  1999-10       Impact factor: 3.209

View more
  6 in total

Review 1.  Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS.

Authors:  Benjamin D Clarkson; Erika Héninger; Melissa G Harris; JangEun Lee; Matyas Sandor; Zsuzsanna Fabry
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases.

Authors:  Alla L Zozulya; Emily Reinke; Dana C Baiu; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

3.  Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis.

Authors:  A Sanna; M L Fois; G Arru; Y-M Huang; H Link; M Pugliatti; G Rosati; S Sotgiu
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

Review 4.  Brain dendritic cells: biology and pathology.

Authors:  Paul M D'Agostino; Andres Gottfried-Blackmore; Niroshana Anandasabapathy; Karen Bulloch
Journal:  Acta Neuropathol       Date:  2012-07-24       Impact factor: 17.088

5.  Modulation of dendritic cell development by immunoglobulin G in control subjects and multiple sclerosis patients.

Authors:  K Ohkuma; T Sasaki; S Kamei; S Okuda; H Nakano; T Hamamoto; K Fujihara; I Nakashima; T Misu; Y Itoyama
Journal:  Clin Exp Immunol       Date:  2007-09-27       Impact factor: 4.330

Review 6.  Immune heterogeneity in neuroinflammation: dendritic cells in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-01       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.